𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of transforming-growth-factor (TGF)-β receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-β1

✍ Scribed by Ester Piek; Ulrica Westermark; Marianne Kastemar; Carl-Henrik Heldin; E. Joop van Zoelen; Monica Nistér; Peter Ten Dijke


Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
268 KB
Volume
80
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


A panel of 6 human glioma cell lines was examined for TGF-␤1 responsiveness. U-178 MG and U-251 MG AgCl1 were significantly inhibited by TGF-␤1, while U-343 MGa 31L and U-343 MGa 35L were potently stimulated to proliferate. TGF-␤1 induced endogenous PAI-1 protein synthesis, Smad binding element/(CAGA) 12 -luciferase-reporter activity, as well as mRNA expression of Smad6 and Smad7 in all gliomas. Interestingly, TGF-␤1 differentially stimulated or inhibited the expression of T␤R-I and T␤R-II mRNA in the gliomas. Affinity cross-linking studies using 125 I-TGF-␤1 revealed that the gliomas expressed TGF-␤-type-I(T␤R-I) and -type-II(T␤R-II) receptors, although binding to T␤R-II in U-343 MGa 31L and U-251 MG AgCl1 was low to undetectable. Smad2 protein was abundantly present in U-178 MG, U-343 MG, and U-343 MGa 35L, while Smad3 was readily detectable in U-178 MG, U-343 MG, U-343 MGa 35L and U-251 MG AgCl1. In all gliomas, TGF-␤1 induced phosphorylation of Smad2. The level to which TGF-␤1 could activate the pathway leading to induction of the (CAGA) 12 -luciferase reporter seemed to correlate to the expression levels of TGF-␤ receptors, Smad3 and Smad4 proteins. However, despite the plethora of data regarding TGF-␤1 signalling in the different glioma cell lines, the mechanism underlying the differential growth effects mediated by TGF-␤1 is still unclear. The results suggest that a complex balance between several components in the TGF-␤ signalling pathway controls glioma responsiveness to TGF-␤1, and extend reports indicating that distinct signal transduction pathways are involved in growth inhibition and other cellular responses.


📜 SIMILAR VOLUMES


Genetic integrity of transforming growth
✍ Shin H. Kang; Kyungshick Won; Hwan-Wook Chung; Hyun-Soon Jong; Yong-Sang Song; S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 166 KB

Transforming growth factor beta (TGF-beta) exerts an inhibitory effect on the growth of most epithelial cell types, and the loss of responsiveness to this growth inhibition has been implicated in the development of a variety of human cancers. The genetic alteration of TGF-beta receptors is known to

Down-regulation of protein and mRNA expr
✍ Yanping Guo; Stephen C. Jacobs; Natasha Kyprianou 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi

Response to transforming growth factor α
✍ G. Hege Thoresen; Tormod K. Guren; Dagny Sandnes; Matthew Peak; Loranne Agius; T 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views

The epidermal growth factor (EGF) receptor mediates the effects of both EGF and transforming growth factor alpha (TGFalpha). Recent data suggested that EGF acts as a partial agonist/antagonist in hepatocytes, TGFalpha exerting a larger maximal stimulation of DNA synthesis than EGF. To further study

Transient upregulation of CBFA1 in respo
✍ Mi-Hye Lee; Amjad Javed; Hyun-Jung Kim; Hong-In Shin; Soraya Gutierrez; Je-Yong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

The bone morphogenetic protein (BMP)-2 is a potent osteoinductive signal, inducing bone formation in vivo and osteoblast differentiation from non-osseous cells in vitro. The runt domain-related protein Cbfa1/PEBP2␣A/ AML-3 is a critical component of bone formation in vivo and transcriptional regulat